These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38716552)

  • 1. Fisetin from Dietary Supplement to a Drug Candidate: An Assessment of Potential.
    Mirza MA; Padhi S; Mohapatra S; Mahmood S; Iqbal Z
    Curr Pharm Biotechnol; 2024 Apr; ():. PubMed ID: 38716552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
    Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
    Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine.
    Mehta P; Pawar A; Mahadik K; Bothiraja C
    Biomed Pharmacother; 2018 Oct; 106():1282-1291. PubMed ID: 30119198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies.
    Qaed E; Al-Hamyari B; Al-Maamari A; Qaid A; Alademy H; Almoiliqy M; Munyemana JC; Al-Nusaif M; Alafifi J; Alyafeai E; Safi M; Geng Z; Tang Z; Ma X
    Glob Med Genet; 2023 Sep; 10(3):205-220. PubMed ID: 37565061
    [No Abstract]   [Full Text] [Related]  

  • 5. Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead.
    Vishwas S; Singh SK; Gulati M; Awasthi A; Khursheed R; Corrie L; Kumar R; Collet T; Loebenberg R; Porwal O; Gupta S; Jha NK; Gupta PK; Devkota HP; Chellappan DK; Gupta G; Adams J; Dua K
    Chem Biol Interact; 2022 Apr; 356():109869. PubMed ID: 35231453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin.
    Rauf A; Abu-Izneid T; Imran M; Hemeg HA; Bashir K; Aljohani ASM; Aljohani MSM; Alhumaydhi FA; Khan IN; Bin Emran T; Gondal TA; Nath N; Ahmad I; Thiruvengadam M
    Curr Top Med Chem; 2023; 23(21):2075-2096. PubMed ID: 37431899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.
    Adhami VM; Syed DN; Khan N; Mukhtar H
    Biochem Pharmacol; 2012 Nov; 84(10):1277-81. PubMed ID: 22842629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fisetin-In Search of Better Bioavailability-From Macro to Nano Modifications: A Review.
    Szymczak J; Cielecka-Piontek J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fisetin: An anticancer perspective.
    Imran M; Saeed F; Gilani SA; Shariati MA; Imran A; Afzaal M; Atif M; Tufail T; Anjum FM
    Food Sci Nutr; 2021 Jan; 9(1):3-16. PubMed ID: 33473265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.
    Rengarajan T; Yaacob NS
    Eur J Pharmacol; 2016 Oct; 789():8-16. PubMed ID: 27377217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eugenol as a Potential Drug Candidate: A Review.
    Taleuzzaman M; Jain P; Verma R; Iqbal Z; Mirza MA
    Curr Top Med Chem; 2021; 21(20):1804-1815. PubMed ID: 34218781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin: a dietary antioxidant for health promotion.
    Khan N; Syed DN; Ahmad N; Mukhtar H
    Antioxid Redox Signal; 2013 Jul; 19(2):151-62. PubMed ID: 23121441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile.
    Singh S; Sharma A; Monga V; Bhatia R
    Crit Rev Food Sci Nutr; 2023; 63(27):8868-8899. PubMed ID: 35357240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics.
    Kumar RM; Kumar H; Bhatt T; Jain R; Panchal K; Chaurasiya A; Jain V
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fisetin and Its Role in Chronic Diseases.
    Pal HC; Pearlman RL; Afaq F
    Adv Exp Med Biol; 2016; 928():213-244. PubMed ID: 27671819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-A systematic review.
    Prem PN; Sivakumar B; Boovarahan SR; Kurian GA
    Phytomedicine; 2022 Jul; 101():154123. PubMed ID: 35533608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of synthesized fisetin glucoside by dextransucrase from Leuconostoc mesenteroides NRRL B-1299CB4 with enhanced water solubility.
    Moon Y; Kim H; Kang CG; Park C; Kim SW; Kim D
    Enzyme Microb Technol; 2022 Nov; 161():110111. PubMed ID: 35961060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Fisetin in Selected Malignant Neoplasms in Women.
    Markowska A; Antoszczak M; Kacprzak K; Markowska J; Huczyński A
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials.
    Mangla B; Javed S; Sultan MH; Kumar P; Kohli K; Najmi A; Alhazmi HA; Al Bratty M; Ahsan W
    Phytother Res; 2021 Oct; 35(10):5440-5458. PubMed ID: 34184327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.